Dr. Falk PharmaFalk Foundation
  • About us
    About us
    • Now into the future
    • Innovation drives everything
    • Why we are
    • Partnering
    • Corporate Sustainability
    • Following the footsteps of our founder
    • Global presence
  • Events
    Events
    • Falk Forums
    • Falk Futures
    • Symposia
  • Falk Foundation Awards
    Falk Foundation Awards
    • Falk Foundation / Guts UK Awards
    • Falk Foundation Awards Ireland
    • Falk Foundation / BASL Awards
  • Product Overview
    Product Overview
    • Budenofalk®
    • Jorveza®
    • Salofalk®
    • Ursofalk®
  • Healthcare Professionals
    Healthcare Professionals
    • Eosinophilic Oesophagitis (EoE)
    • Inflammatory Bowel Diseases
    • Liver Diseases
    • Falk News
    • Our Apps
    • FalkPlus
    • Resources
  • Patient Support
    Patient Support
    • Eosinophilic Oesophagitis (EoE)
    • Inflammatory Bowel Diseases
    • Liver Diseases
    • Patient Apps
  • Falk+
Search
Please choose your country
  • Global (English)
  • Australia
  • België (Vlaams)
  • Belgique (Français)
  • Deutschland
  • España
  • France
  • Ireland
  • Italia
  • Luxembourg (Français)
  • Nederland
  • Österreich
  • Portugal
  • Россия
  • Schweiz (Deutsch)
  • Suisse (Français)
  • United Kingdom
more info

Contact:
Phone:+44 (0)1628 536600 Email: office@drfalkpharma.co.uk

  • Contact
  • Newsroom
  • Our Partnerships
  • Falk Foundation
  • Reporting misconduct
  • Declaration
  • Reporting Adverse Events
  • Basket
  • My Account
  • Follow us on X
  • Follow us on Linkedin
Login
  • About us
    • Now into the future
    • Innovation drives everything
    • Why we are
    • Partnering
    • Corporate Sustainability
    • Following the footsteps of our founder
    • Global presence
  • Events
    • Falk Forums
    • Falk Futures
    • Symposia
  • Falk Foundation Awards
    • Falk Foundation / Guts UK Awards
    • Falk Foundation Awards Ireland
    • Falk Foundation / BASL Awards
  • Product Overview
    • Budenofalk®
    • Jorveza®
    • Salofalk®
    • Ursofalk®
  • Healthcare Professionals
    • Eosinophilic Oesophagitis (EoE)
    • Inflammatory Bowel Diseases
    • Liver Diseases
    • Falk News
    • Our Apps
    • FalkPlus
    • Resources
  • Patient Support
    • Eosinophilic Oesophagitis (EoE)
    • Inflammatory Bowel Diseases
    • Liver Diseases
    • Patient Apps
  • Falk+
  • Contact
  • Newsroom
  • Our Partnerships
  • Falk Foundation
  • Reporting misconduct
  • Declaration
  • Reporting Adverse Events
  • Basket
  • My Account
  • Follow us on X
  • Follow us on Linkedin
Contact:
Phone:
+44 (0)1628 536600
Email:
office[at]drfalkpharma.co.uk
  • Homepage
  • Search

Search results

189 results

  • Policy Statement
    Policy Statement Homepage About us Corporate Sustainability Policy Statement Policy Statement for Dr. Falk Pharma GmbH and its Affiliated Companies Preface As a family-run and family-owned company, we…
  • Reporting Misconduct
    Reporting Misconduct Homepage Reporting misconduct Suspected misconduct Reports concerning actual or suspected misconduct can be given via our reporting system - also anonymously: File a report
  • Resources
    Ultrasound of the Liver Malignant Liver Lesions - UI--2200186
    QR code
  • NEWSROOM
    Back to the Future – Unleashing the Power of Established Drugs
    Lunch satellite symposium on 21.02.2025 during the Congress of ECCO in Berlin
  • Resources
    A Patient Story: Part 1 - Dealing with symptoms and the journey to diagnosis
    Watch
  • Resources
    A Patient Story: Part 3 - Getting and EoE Diagnosis
    Watch
  • Resources
    A Patient Story: Part 4 - Life on Treatment
    Watch
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • »
Falk Foundation

Discover the range of continuing education opportunities for physicians and pharmacists provided by the Falk Foundation e.V.

Dr. Falk Pharma UK

Dr. Falk Pharma is the expert in digestive and metabolic medicine. As a research-based family business with global presence, we focus on the development and distribution of innovative medicines that improve patients’ health and well-being.

  • About us
  • Events
  • Contact
  • Reporting misconduct
  • Basket
  • Products
  • Patients
  • Social Media Community Guidelines
  • Reporting Adverse Events
© 2025 Dr. Falk Pharma UK Ltd | Company Registration Number: 2307698
  • Privacy Policy
  • Terms & Conditions
Notice

This website is an international information resource intended for healthcare professionals outside the United States (US) and United Kingdom (UK).

I am a health care professional outside the US and UK.

Accept
UK Login
Notice
I confirm I am a UK or Irish resident and have been prescribed either Budenofalk®, Jorveza®, Salofalk® or Ursofalk®
Accept

You are now leaving uk.drfalkpharma.com for an external website.

Dr Falk Pharma UK accepts no responsibility for the content of other websites.